Inhibrx Biosciences (INBX) Price-to-Earnings (P/E) Ratio
Price: $11.47
Market Cap: $166.04M
Avg Volume: 110.12K
Market Cap: $166.04M
Avg Volume: 110.12K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Inhibrx Biosciences's P/E ratios across different time periods:
- TTM: 0.10
- Annual: 0.14
- Quarterly: -1.19
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 1.71
- Price-to-Sales (P/S) Ratio: 1139.75
Annual Ratios
Inhibrx Biosciences Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
0.10
P/B Ratio (Annual)
1.71
P/S Ratio (Annual)
1139.75
Inhibrx Biosciences Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | 0.14 | 1.71 | 1139.75 |
| 2023 | -7.42 | 41.17 | 994.97 |
| 2022 | -6.80 | 17.02 | 453.75 |
| 2021 | -20.30 | 31.69 | 232.97 |
| 2020 | -11.01 | 11.04 | 65.03 |
| 2019 | -14.67 | -8.06 | 82.93 |
| 2018 | -17.93 | -9.69 | 74.48 |
| 2017 | -30.55 | -20.64 | 74.71 |
| 2016 | -91.20 | -81.55 | 113.11 |
Related Metrics
Explore detailed financial metrics and analysis for INBX.